本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mersana Therapeutics Inc.

27.92
+0.49001.79%
盘前27.46-0.4600-1.65%05:55 EST
成交量:42.03万
成交额:1,163.04万
市值:1.40亿
市盈率:-1.87
高:28.12
开:27.21
低:27.11
收:27.43
52周最高:70.73
52周最低:5.21
股本:499.88万
流通股本:375.34万
量比:0.64
换手率:11.20%
股息:- -
股息率:- -
每股收益(TTM):-14.9441
每股收益(LYR):-14.1163
净资产收益率:-505.14%
总资产收益率:-34.11%
市净率:-2.63
市盈率(LYR):-1.98

数据加载中...

2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/10

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities